Bio-Techne Corporation
TypePublic company
IndustryBiotechnology
Founded1976 (1976)
FounderDr. Roger C. Lucas
HeadquartersMinneapolis, Minnesota, U.S.
Key people
Chuck Kummeth, President & CEO
James Hippel, CFO
Robert V. Baumgartner, Chairman
ProductsProteins
Reagents
Diagnostic instruments
RevenueIncrease US$1.120 billion (2022)
Increase US$229 million (2020)
Total assetsIncrease US$2.027 billion (2020)
Total equityIncrease US$1.381 billion (2020)
Number of employees
2,300 (2020)
Websitebio-techne.com
Footnotes / references
[1]

Bio-Techne Corporation develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets. The company's brands include R&D Systems, ProteinSimple, and Novus Biologicals.[1]

History

The company was founded in 1976 by Dr. Roger C. Lucas as Research and Diagnostic Systems, Inc. In 1985, it merged into Techne Corporation and became a public company.[1]

In March 2013, Charles (Chuck) Kummeth was named chief executive officer of the company.[2]

In July 2013, the company acquired Bionostics for $104 million.[3][4]

In February 2014, the company changed its name to Bio-Techne.[5]

In April 2014, the company agreed to acquire Shanghai PrimeGene Bio-Tech Company (PrimeGene).[6][7]

In July 2014, the company acquired Novus Biologicals for $60 million.[8][9][10]

In August 2014, the company acquired ProteinSimple for $300 million.[11]

In November 2014, the company agreed to acquire CyVek for $60 million plus up to an additional $135 million in earn-out payments.[12][13][14]

In June 2015, the company agreed to acquire Cliniqa Corporation.[15][16]

In March 2016, the company acquired Zephyrus Biosciences.[17][18][19]

In July 2016, the company acquired Space Import-Export.[20]

In August 2016, company acquired Advanced Cell Diagnostics for $250 million plus an additional $75 million in possible milestone payments.[21][22][23]

In September 2017, the company acquired Trevigen.[24][25]

In January 2018, the company acquired Atlanta Biologicals.[26][27]

In June 2018, the company agreed to acquire Quad Technologies.[28][29]

In August 2018, the company acquired Exosome Diagnostics for $250 million plus up to an additional $325 million in milestone payments.[30]

In June 2019, the company acquired B-Mogen.[31][32]

In April 2021, the company acquired Asuragen for $215 million plus up to an additional $105 million in milestone payments.[33]

In June 2022, the business announced it would acquire Namocell Inc.[34]

In June 2023, Bio-Techne announced it would acquire Lunaphore Technologies SA,[35] the transaction was completed the following month[36]

References

  1. 1 2 3 "Bio-Techne Corporation 2020 Form 10-K Annual Report". U.S. Securities and Exchange Commission.
  2. ↑ "Board Of Directors Appoints Charles Kummeth As Chief Executive Officer And Director Of Techne Corporation" (Press release). PR Newswire. March 18, 2013.
  3. ↑ Resende, Patricia (July 23, 2013). "Techne Corp. completes $104M cash purchase of Bionostics, names new CTO". American City Business Journals.
  4. ↑ "Local company news". Star Tribune. July 22, 2013.
  5. ↑ "Techne Corporation Announces New Trade Name, Bio-Techne". PR Newswire. February 10, 2014.
  6. ↑ "Bio-Techne Announces Acquisition Agreement". PR Newswire. April 15, 2014.
  7. ↑ Hammerand, Jim (April 15, 2014). "Techne has deal to buy Chinese genetics firm". American City Business Journals.
  8. ↑ "Bio-Techne Acquires Novus Biologicals for $60M". genengnews.com. July 3, 2014.
  9. ↑ "Bio-Techne Announces Agreement to Acquire Novus Biologicals for $60M". The Wall Street Journal. July 3, 2014.
  10. ↑ "Bio-Techne Announces Agreement To Acquire Novus Biologicals". PR Newswire. July 2, 2014.
  11. ↑ "Bio-Techne Announces ProteinSimple Acquisition Completion" (Press release). PR Newswire. August 1, 2014.
  12. ↑ "Bio-Techne Announces Agreement To Acquire CyVek" (Press release). PR Newswire. November 4, 2014.
  13. ↑ "Bio-Techne to Acquire CyVek for Up to $195M+". genengnews.com. November 5, 2014.
  14. ↑ "Wallingford's CyVek acquired by Minnesota company". New Haven Register. November 13, 2014.
  15. ↑ "Bio-Techne Corporation Agrees to Acquire Cliniqa Corporation" (Press release). PR Newswire. June 5, 2015.
  16. ↑ "Cliniqa Now Owned by Bio-Techne". genengnews.com. June 5, 2015.
  17. ↑ "Bio-Techne Corporation Agrees to Acquire Zephyrus Biosciences, Inc" (Press release). PR Newswire. March 21, 2016.
  18. ↑ "Bio-Techne Acquires Zephyrus Biosciences". genengnews.com. March 21, 2016.
  19. ↑ "Bio-Techne Acquires Zephyrus Biosciences". The Wall Street Journal. March 22, 2016.
  20. ↑ "Bio-Techne Acquires Space Import-Export And Strengthens European Leadership Team" (Press release). PR Newswire. July 1, 2016.
  21. ↑ "Bio-Techne Corporation Completed its Acquisition of Advanced Cell Diagnostics" (Press release). PR Newswire. August 1, 2016.
  22. ↑ "Bio-Techne to Acquire Advanced Cell Diagnostics for Up to $325M". genengnews.com. July 7, 2016.
  23. ↑ Al Idrus, Amirah (July 7, 2016). "MedTech Bio-Techne shells out $250M for Advanced Cell Diagnostics". FierceBiotech.
  24. ↑ "Bio-Techne Acquires Trevigen Inc" (Press release). PR Newswire. September 5, 2017.
  25. ↑ Bakolia, Ravikash (September 5, 2017). "Bio-Techne acquires privately held Trevigen". S&P Global.
  26. ↑ "Bio-Techne Acquires Atlanta Biologicals Inc" (Press release). PR Newswire. January 2, 2018.
  27. ↑ Carlson, Joe (January 2, 2018). "Bio-Techne buys Atlanta Biologicals in cash deal". Associated Press.
  28. ↑ "Bio-Techne To Acquire Quad Technologies" (Press release). PR Newswire. June 7, 2018.
  29. ↑ Bakolia, Ravikash (June 7, 2018). "Bio-Techne to acquire privately held Quad Technologies". S&P Global.
  30. ↑ "Bio-Techne Corporation Completed Its Acquisition of Exosome Diagnostics, Inc" (Press release). PR Newswire. August 1, 2018.
  31. ↑ "Bio-Techne To Acquire B-MoGen Biotechnologies Inc" (Press release). PR Newswire. June 4, 2019.
  32. ↑ Wittenberg, Alex (June 5, 2019). "Bio-Techne acquires Minneapolis gene-editing firm formed at U of M". American City Business Journals.
  33. ↑ "Bio-Techne Completes Acquisition of Asuragen, Inc" (Press release). PR Newswire. April 6, 2021.
  34. ↑ "Bio-Techne to Acquire Namocell".
  35. ↑ https://investors.bio-techne.com/press-releases/detail/373/bio-techne-to-acquire-lunaphore
  36. ↑ https://www.biospace.com/article/releases/bio-techne-completes-lunaphore-acquisition/?s=79
  • Official website
  • Business data for Bio-Techne Corporation:
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.